Has Rona Yaeger, MD received payments from drug or device companies?

Yes. Drug and device makers reported $21,536 in general payments to Rona Yaeger, MD across 27 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Rona Yaeger, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Rona Yaeger, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Rona Yaeger, MD

Medical Oncology · New York, NYNPI 1790931384

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $17,465 of the $21,536 with a category attached, or 81.1%. Merck accounts for 80.2% of it on its own, with 6 other manufacturers making up the rest. 2025 is the largest year on record at $9,956, more than ten times the $792 reported in 2022.

$21,536in general payments, 2019–2025

Across 27 payments — averaging $797.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Merck$17K
Eli Lilly$2K
Mirati Therapeutics, Inc.$904
Boehringer Ingelheim International GmbH$780
Pfizer$650
Amgen$198
plus $118 from 1 others

$17,133,272in research payments, 2019–2025

Across 468 payments — averaging $36,610 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Array Biopharma Inc$9.1M
Pfizer$4.6M
Mirati Therapeutics, Inc.$1.7M
Amgen$1.3M
Boehringer Ingelheim$279K
Eli Lilly$119K
plus $131K from 3 others

What the payments were for

Consulting fees$17,46581%
Speaking & faculty fees$7804%
Travel & lodging$2,80613%
Food & beverage$4862%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Merck	16	$17,274
Eli Lilly	2	$1,613
Mirati Therapeutics, Inc.	3	$904
Boehringer Ingelheim International GmbH	2	$780
Pfizer	1	$650
Amgen	1	$198
Array Biopharma Inc	2	$118

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$21,536 in reported general payments places this provider in the 65th percentile of 498 medical oncology providers in New York.

See all medical oncology providers in New York →

Medicare billing

Part B allowed, 2024

$39,995

Medicare patients

102

Services billed

376

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Ondansetron Hcl	31	$944
Doxycycline Hyclate	17	$175
Lorazepam	18	$64
Pantoprazole Sodium	11	$51

Paid to pharmacies, not to this prescriber.

Other medical oncology in New York

Craig ThompsonNew York$4.8M
Andrew SeidmanNew York$1.3M
Joshua RichterNew York$971K
Edward GelmannNew York$944K
Ghassan Abou-AlfaNew York$825K
Miguel PeralesNew York$769K
Komal JhaveriNew York$642K
Joshua BrodyNew York$492K
Aiwu HeNew York$445K
Raajit RampalNew York$418K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →